Literature DB >> 20569288

Pregnancy during adalimumab use for psoriasis.

C Dessinioti, I Stefanaki, A J Stratigos, M Kostaki, A Katsambas, C Antoniou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20569288     DOI： 10.1111/j.1468-3083.2010.03756.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  3 in total

1.  Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding.

Authors:  Harish Raja; Eric L Matteson; Clement J Michet; Justine R Smith; Jose S Pulido
Journal:  Transl Vis Sci Technol       Date:  2012-09-21       Impact factor: 3.283

Review 2.  Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.

Authors:  Renée M Marchioni; Gary R Lichtenstein
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

Review 3.  Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding.

Authors:  Patricia Shu Kurizky; Clarissa de Castro Ferreira; Lucas Souza Carmo Nogueira; Licia Maria Henrique da Mota
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.